Aviron, Avivir

The Aviron project of ChemRar Group implements a program for the development of innovative antiviral drugs with different complementary mechanisms of action for the treatment of chronic hepatitis C, which is included in the list of socially significant diseases and known as “the silent killer”. The scientific team of the project has already completed the creation of a product line. All selected candidate drugs are best in their class, demonstrating the characteristics beyond those of the headliners of the world market leaders in preclinical and clinical studies.